Insider Trading April 16, 2026 04:37 PM

LPL Financial CFO Executes $518,900 Stock Sale Under 10b5-1 Plan

Matthew Audette disposed of 1,579 LPLA shares across April 14-15, 2026; company posts asset growth and strategic deals amid analyst upgrades

By Avery Klein LPLA
LPL Financial CFO Executes $518,900 Stock Sale Under 10b5-1 Plan
LPLA

Matthew J. Audette, President and Chief Financial Officer of LPL Financial Holdings Inc. (NASDAQ: LPLA), sold 1,579 shares of common stock on April 14 and 15, 2026, for $518,900 under a Rule 10b5-1 trading plan. The transactions were completed at prices above the current market quote of $312.57 and InvestingPro's Fair Value of $331.15. LPL reported asset growth in February and announced strategic acquisitions and partnerships while receiving recent analyst upgrades.

Key Points

  • CFO Matthew J. Audette sold 1,579 LPLA shares for $518,900 under a Rule 10b5-1 plan adopted August 14, 2025 - impacts corporate governance and insider trading transparency.
  • LPL reported total advisory and brokerage assets of $2.43 trillion at February end, up $22.3 billion from January, with advisory assets at $1.44 trillion and brokerage assets at $989.3 billion - relevant to financial services and wealth management sectors.
  • Company strategic moves include the announced acquisition of Mariner Advisor Network (367 advisors, $31 billion in assets) and a May 2026 strategic insurance agreement with Simplicity Group - pertinent to M&A and insurance distribution within financial services.

Matthew J. Audette, who serves as President and Chief Financial Officer of LPL Financial Holdings Inc. (NASDAQ: LPLA), reported the sale of 1,579 shares of the company's common stock on April 14 and April 15, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The aggregate proceeds from those disposals totaled $518,900, with individual trade prices spanning from $325.00 to $332.27.

The disposals were carried out in a series of executed trades over the two days. On April 14, Audette sold two lots: 330 shares at a weighted average price of $325.00, with trade prices between $325.00 and $325.01, producing $107,250; and 139 shares at a weighted average price of $326.16, with trade prices from $326.12 to $326.33, producing $45,336.

On April 15, the filings show four separate sales. The first was 220 shares at a weighted average price of $327.45, with prices ranging from $326.93 to $327.47, resulting in $71,000. The next lot comprised 189 shares at a weighted average of $328.34, with prices between $328.34 and $328.35, netting $62,056. A subsequent block of 595 shares sold at a weighted average price of $331.09, with trade prices between $330.69 and $331.56, generating $197,000. The final reported sale was 106 shares at a weighted average price of $332.27, with prices from $331.69 to $332.43, for $35,220.

Following these transactions, Audette is listed as directly owning 19,803 shares of LPL Financial. The Form 4 indicates the trades were made pursuant to a Rule 10b5-1 trading plan that Audette adopted on August 14, 2025.

At the time of reporting, LPL Financial's common stock was trading at $312.57, which is below the range of prices at which Audette sold shares and below InvestingPro's Fair Value estimate of $331.15. That price relationship is noted in the filing and suggests the reported sale prices exceeded the current market quote.


Company operational and strategic updates

LPL Financial reported total advisory and brokerage assets of $2.43 trillion as of the end of February, an increase of $22.3 billion from January. Within that aggregate, advisory assets rose to $1.44 trillion, a 1.3% month-over-month increase, while brokerage assets increased by 0.4% to $989.3 billion.

On the strategic front, LPL announced an agreement to acquire Mariner Advisor Network. The network supports 367 financial advisors overseeing $31 billion in assets. Under the terms described, Private Advisor Group will integrate Mariner’s hybrid advisors into its Registered Investment Advisor model in cooperation with LPL.

Separately, LPL has entered into a strategic agreement with Simplicity Group to strengthen insurance offerings available to its advisors, with that partnership set to take effect in May 2026.


Analyst coverage

Recent analyst moves have reflected growing optimism among some firms. UBS upgraded LPL Financial to a Buy rating from Neutral and set a $380.00 price target, noting that concerns tied to AI-related risks may be overstated. Citizens reiterated a Market Outperform rating with a $500.00 price target, while noting the stock has underperformed both peers and the broader market.

The company's reported price-to-earnings ratio is 28.92. The filing and coverage notes also reference that InvestingPro subscribers have access to 11 additional exclusive tips for LPLA.


Takeaway

The Form 4 filing documents a controlled set of sales by LPL's CFO under an established 10b5-1 plan, executed at prices above current market levels and above InvestingPro's Fair Value estimate. Those trades coincide with company disclosures showing month-over-month asset growth, an acquisition agreement to add advisor capacity, a strategic insurance partnership, and recent analyst upgrades.

Risks

  • Stock is trading at $312.57, below the prices at which the CFO sold shares (range $325.00 to $332.27) and below InvestingPro's Fair Value of $331.15 - market valuation risk for investors in financials and wealth management sectors.
  • Analyst viewpoints differ despite upgrades - UBS and Citizens provided higher price targets ($380.00 and $500.00 respectively) while noting recent underperformance, leaving uncertainty in market sentiment and relative valuation.
  • The company is pursuing acquisitions and partnerships (Mariner Advisor Network, Simplicity Group) that may introduce integration and execution risks affecting advisory, brokerage and insurance distribution operations.

More from Insider Trading

Kymera Therapeutics CBO Executes $121,230 Stock Sale as Company Posts Clinical and Partnership Milestones Apr 16, 2026 Kymera COO Disposes $589,598 of Stock as Options Exercised Under 10b5-1 Plan Apr 16, 2026 Kymera Therapeutics Director Executes $854,538 Stock Sale, Exercises Options Amid Pipeline Progress Apr 16, 2026 Samsara CEO Disposes $7.15M in Stock Across Two Days; Shares Rise After Trades Apr 16, 2026 Clearwater Analytics CFO Disposes $450K in Stock as Buyout Looms Apr 16, 2026